Drug maker tests different injection pens in healthy volunteers
NCT ID NCT06908577
Summary
This study tested whether two different injection devices—a prefilled syringe and an autoinjector pen—deliver the same amount of an experimental drug called tozorakimab into the body. Researchers gave a single injection to 254 healthy volunteers and tracked the drug levels in their blood for 16 weeks. The goal was to see if the two devices work equally well, which is a standard early step in drug development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
-
Research Site
Baltimore, Maryland, 21225, United States
-
Research Site
Berlin, 14050, Germany
-
Research Site
Harrow, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.